Work

A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridol

Year: 2010

Type: article

Study design: Clinical Trial

Source: Cancer Chemotherapy and Pharmacology

DOI: 10.1007/s00280-010-1269-1

Authors: Mark A. Dickson, Manish A. Shah, Dana Rathkopf, Archie Tse, Richard D. Carvajal, Nian Wu, Robert A. Lefkowitz, Mithat Gonen, Lauren M. Cane, Heather J. Dials, Gary K. Schwartz

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Awards: G1740525510, G4053808062, Clinical Trials of Flavopiridol with Chemotherapy

OpenAlex ID: W2005393395

FWCI: 1.992

Cites: 28

Cited by: 30

Related to: 10